Proportion of patients who received medications thoughout the post-stroke period.

Abstract

Mucoprotective agents include rebamipide, teprenone, irsogladine, ecabet, polaprezinc, sofalcone, sucralfate, and misoprostol. Abbreviations: H2RA, H2-receptor antagonist; PPI, proton-pump inhibitor.</p